A Procedure for Evaluating Luteolytic Agents in Primates

  • John W. Wilks
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 112)


A method of human fertility control based on the regulation of corpus luteum function has been the objective of a continuing research effort by reproductive biologists. The vast array of physiologic control mechanisms governing the corpus luteum among the mammalian species presents a formidable obstacle in extrapolating concepts developed in animal research for clinical application in women. As an example the uterus clearly regulates the secretory activity and life span of the corpus luteum in infraprimate animals, but a role for the uterus in altering luteal function in primates has not been established. The importance of this biological distinction is illustrated by the successful application of prostaglandin F (a physiologic luteolytic substance of uterine origin) to the regulation of estrous cycles in domestic animals (1), and the disappointing outcome of a clinical evaluation of this prostaglandin for control of the human corpus luteum (2).


Menstrual Cycle Rhesus Monkey Corpus Luteum Control Monkey Serum Progesterone 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. (1).
    J. W. Lauderdale, B. E. Seguin, J. N. Stellflug, J. R. Chenault, W. W. Thatcher, C. K. Vincent and A. F. Loyancano. J. Anim. Sci. 38 (1974) 964.PubMedGoogle Scholar
  2. (2).
    W. J. LeMaire and A. G. Shapiro. Prostaglandins 1 (1972) 259.PubMedCrossRefGoogle Scholar
  3. (3).
    E. L. Klaiber, M. R. Henzl, C. W. Lloyd and E. J. Segre. J. Clin. Endocrinol. Metab. 36 (1973) 142.PubMedCrossRefGoogle Scholar
  4. (4).
    P. F. Brenner and D. R. Mishell. Contraception 11 (1975) 669.PubMedCrossRefGoogle Scholar
  5. (5).
    M. R. Henzl, E. J. Segre and R. M. Nakamura. Contraception 8 (1973) 515.CrossRefGoogle Scholar
  6. (6).
    E. Knobil. Biol. Reprod. 8 (1973) 246.Google Scholar
  7. (7).
    J. D. Neill and E. Knobil. Endocrinology 90 (1972) 34.PubMedCrossRefGoogle Scholar
  8. (8).
    G. D. Hodgen, W. W. Tullner, J. L. Vaitukaitis, D. N. Ward and G. T. Ross. J. Clin. Endocrinol. Metab. 39 (1974) 457.PubMedCrossRefGoogle Scholar
  9. (9).
    L. E. Atkinson, J. Hotchkiss, G. R. Fritz, A. H. Surve, J. D. Neill and E. Knobil. Biol. Reprod. 12 (1975) 335.PubMedCrossRefGoogle Scholar
  10. (10).
    J. W. Wilks, G. D. Hodgen and G. T. Ross. J. Clin. Endocrinol. Metab. 43 (1976) 1261.Google Scholar
  11. (11).
    J. W. Wilks, A. S. Noble, A. D. Forbes and K. K. Forbes. Abstracts, 10th Annual Meeting, Society for the Study of Reproduction (1977) p. 19.Google Scholar
  12. (12).
    E. Knobil, J. D. Neill and E. D. B. Johansson. Endocrinology 82 (1968) 410.PubMedCrossRefGoogle Scholar
  13. (13).
    H. P. Schaue, J. E. Creange and G. O. Potts. Fertil. Steril. 28 (1977) 301.Google Scholar
  14. (14).
    W. T. K. Bosu and E. D. B. Johansson. Fertil. Steril. 25 (1974) 443.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1979

Authors and Affiliations

  • John W. Wilks
    • 1
  1. 1.Fertility ResearchThe Upjohn CompanyKalamazooUSA

Personalised recommendations